Search clinical trials for: Drisapersen

Total 4 results

BioMarin Pharmaceutical

No longer available

Extension Study of Drisapersen in DMD Subjects

Duchenne Muscular Dystrophy

United States, Germany, United Kingdom, Japan, Netherlands, France, Spain, Korea, Republic of, Italy, Belgium, Taiwan, Argentina, Australia, Bulgaria, Czechia, Israel, Norway, Poland, Russian Federation, Turkey
BioMarin Pharmaceutical

Terminated

A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess Effect, Safety, Tolerability and PK of Multiple SC Doses of Drisapersen in Patients With Duchenne Muscular Dystrophy and to Assess the Potential for IV Dosing as an Alternative Route of Administration

Muscular Dystrophies
GlaxoSmithKline

Withdrawn

Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol

Muscular Dystrophies
BioMarin Pharmaceutical

Terminated

A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects

Muscular Dystrophies

United States, Canada

3

Subscribe